Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT06242691
Title Safety and Efficacy of MK-1200 in Participants With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Merck Sharp & Dohme LLC
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | AUS

Facility Status City State Zip Country Details
South Texas Accelerated Research Therapeutics (START) ( Site 0005) RECRUITING San Antonio Texas 78229 United States Details
The Alfred Hospital ( Site 0103) RECRUITING Melbourne Victoria 3004 Australia Details
Rambam Health Care Campus-Oncology Division ( Site 0602) RECRUITING Haifa 3109601 Israel Details
Hadassah Medical Center ( Site 0604) RECRUITING Jerusalem 9112001 Israel Details
Sheba Medical Center ( Site 0605) RECRUITING Ramat Gan 5265601 Israel Details
Sourasky Medical Center ( Site 0601) RECRUITING Tel Aviv 6423906 Israel Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field